Kyntra Bio, Inc. (KYNB) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Kyntra Bio, Inc. (KYNB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $13.00K (capex $13.00K ) from operating cash flow of $12.68 Million. See KYNB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$13.00K
Capex + Investments
Operating Cash Flow
$12.68 Million
USD
Capital Expenditures
$13.00K
USD
Kyntra Bio, Inc. Cash Flow Reinvestment Rate (2013–2020)
Historical reinvestment intensity for Kyntra Bio, Inc. across 4 annual periods. Explore Kyntra Bio, Inc. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Kyntra Bio, Inc. (2013–2020)
Year-by-year capital reinvestment analysis for Kyntra Bio, Inc.. For the full cash flow conversion analysis, see Kyntra Bio, Inc. cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.05x | $3.99 Million | $81.60 Million | $3.99 Million | ▼ -72.2% |
| 2016 | 0.18x | $1.25 Million | $7.11 Million | $1.25 Million | ▼ -51.4% |
| 2014 | 0.36x | $8.12 Million | $22.41 Million | $8.12 Million | ▲ +37.9% |
| 2013 | 0.26x | $6.81 Million | $25.92 Million | $6.81 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow